Preferred Label : berotralstat;

Obsolete resource : false;

MeSH Hyperonym : 1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide;

MeSH hyponym : BCX-7353;

UNII : XZA0KB1BDQ;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-atu-rtu/berotralstat-150-mg-gelule
2021
false
false
false
France
French
Berotralstat
package leaflet
summary of product characteristics
guidelines for drug use
Berotralstat
pyrazoles
pyrazoles
administration, oral
angioedemas, hereditary
plasma kallikrein
Hereditary angioedema attack
berotralstat
berotralstat
berotralstat

---
https://www.has-sante.fr/jcms/p_3298588/fr/orladeyo-150-mg-berotralstat
2021
false
false
false
France
adult
adolescent
treatment outcome
insurance, health, reimbursement
angioedemas, hereditary
Hereditary angioedema attack
administration, oral
berotralstat
berotralstat
berotralstat
evaluation of the transparency committee

---
https://www.ema.europa.eu/en/medicines/human/EPAR/orladeyo
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
berotralstat
berotralstat
drug approval
europe
angioedemas, hereditary
adult
adolescent
orphan drug production
administration, oral
berotralstat
drug monitoring
aged
drug interactions
pregnancy
breast feeding
plasma kallikrein
drug evaluation, preclinical
Substance with kallikrein inhibitor mechanism of action (substance)
pyrazoles
pyrazoles

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.